Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Olympus and Cytosurge agree partnership
Opfikon ZH - Olympus has agreed a further partnership with the ETH spin-off Cytosurge. The objective of this collaboration is to market single-cell and CRISPR gene manipulation solutions in the Americas. The two partners have been also been working together for a year in the field of development.
Investors won over by artificial muscles
MyoSwiss has raised a total of 2.2 million Swiss francs as part of a financing round. The spin-off from ETH Zurich is developing a suit of artificial muscles aimed at improving the quality of life for people living with disabilities that restrict their mobility.
Biognosys cooperating with Boehringer Ingelheim
Schlieren ZH – The biotech firm Biognosys has agreed a collaboration with the pharmaceutical company Boehringer Ingelheim. Biognosys will bring its expertise in the field of proteomics to the table with the aim of optimizing drug development processes at Boehringer Ingelheim.
LafargeHolcim rolling out green concrete worldwide
Zug – LafargeHolcim has launched a range of green high-performance concrete. Following the successful introduction in Europe, it will now be brought to markets in North and Latin America. The new product will advance the transition towards circular construction.
Ecocoach delivering energy management to Rehl Energy
Brunnen SZ – Ecocoach will be equipping German solar energy company Rehl Energy in Andernach with energy management, power storage and automation. The whole building will be powered by a photovoltaic system.
ETH researchers win award for illuminating tumors
Zurich – Two researchers at ETH Zurich have developed a fluorescent marker that should make a surgeon’s task easier by making tumors visible. They have now been awarded the Spark Award for their invention.
Gain Therapeutics raises $10 million
Lugano – Gain Therapeutics has raised $10 million in a financing round. The company develops medicines for the treatment of rare genetic and neurogenerative diseases.
Empa seeks to make recycling batteries easier
Dübendorf ZH – Fluorine-rich salts make recycling lithium-ion batteries a dangerous and complicated process. Empa researchers have now turned their attention towards solving this problem. To this end, they have already developed a new, non-combustible, water-based electrolyte.
DiNAQOR strengthens development in Greater Zurich
Pfäffikon SZ/Schlieren ZH – The life sciences company DiNAQOR is moving into new research premises at the Bio-Technopark Schlieren-Zurich this fall. The company is planning to drive forward the development of genetic therapies for the treatment of cardiac diseases from its new base.
Meet with an expansion expert
Is Greater Zurich on your expansion radar? We support you on every step of your expansion journey - from location evaluation to fact finding visits.
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Location evaluation support to find the ideal base for your business
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space
- And much more, customized to meet your needs.